The generic name for the medicine Plavix is clopidogrel [1].
Why is Clopidogrel Prescribed?
Clopidogrel is an antiplatelet medication used to prevent blood clots in individuals who have had a recent heart attack or stroke, or who have peripheral arterial disease [1]. It is also prescribed for patients with certain heart conditions, such as those who have undergone procedures like angioplasty or stenting [1]. By inhibiting platelet aggregation, clopidogrel helps to reduce the risk of further cardiovascular events [1].
How Does Clopidogrel Work?
Clopidogrel is a prodrug, meaning it is converted into its active form in the body [2]. The active metabolite irreversibly blocks the P2Y12 adenosine diphosphate (ADP) receptor on the surface of platelets [2]. This blockage prevents ADP from binding to the receptor, thereby inhibiting platelet activation and aggregation [2]. This mechanism helps to keep blood flowing smoothly and prevents the formation of dangerous clots [2].
When Did Clopidogrel's Patents Expire?
The primary U.S. patent for Plavix (clopidogrel bisulfate) expired in 2011 [3]. This expiration opened the door for generic versions of the drug to enter the market.
Who Makes Generic Clopidogrel?
Following the patent expiration of Plavix, multiple pharmaceutical companies began manufacturing and distributing generic clopidogrel [4]. These companies include, but are not limited to, Teva Pharmaceuticals, Mylan, and Aurobindo Pharma [4]. The availability of generics has led to increased competition and typically lower prices for the medication.
What Are the Side Effects of Clopidogrel?
Common side effects associated with clopidogrel use include bruising, bleeding (such as nosebleeds or gastrointestinal bleeding), and rash [1]. More serious side effects, though less common, can involve severe bleeding, thrombotic thrombocytopenic purpura (TTP), and allergic reactions [1]. Patients should report any unusual or severe symptoms to their healthcare provider [1].
How Does Clopidogrel Compare to Aspirin?
Both clopidogrel and aspirin are antiplatelet medications used to prevent blood clots, but they work through different mechanisms and are often used in combination for certain high-risk patients [5]. Aspirin inhibits the cyclooxygenase (COX) enzyme, which reduces the production of thromboxane A2, another substance that promotes platelet aggregation [5]. Clopidogrel targets the P2Y12 receptor. While aspirin is often a first-line treatment for preventing heart attacks and strokes, clopidogrel is frequently prescribed for patients with acute coronary syndromes or those undergoing percutaneous coronary intervention (PCI) [5]. For certain conditions, dual antiplatelet therapy (DAPT) combining both aspirin and clopidogrel is recommended for a specific duration to maximize clot prevention [5].
What Are the Risks of Stopping Clopidogrel Early?
Stopping clopidogrel, especially within the recommended treatment period after a cardiovascular event or procedure like stenting, significantly increases the risk of blood clots forming in arteries [6]. This can lead to a higher chance of experiencing another heart attack, stroke, or stent thrombosis (a clot within the stent), which can be life-threatening [6]. Patients should never discontinue clopidogrel without consulting their physician [6].
Can Biosimilars Be Made for Clopidogrel?
Clopidogrel is a small molecule drug, not a biologic. Therefore, the concept of "biosimilars" does not apply. Instead, generic versions are developed and approved by regulatory agencies, demonstrating they are therapeutically equivalent to the brand-name drug [7].
What is the Cost of Generic Clopidogrel?
The cost of generic clopidogrel can vary depending on the dosage, the pharmacy, insurance coverage, and the specific manufacturer [4]. However, generic medications are generally significantly less expensive than their brand-name counterparts. Online price comparison tools and local pharmacy information can provide specific cost details.
What Are the Regulatory Aspects of Generic Clopidogrel Approval?
In the United States, generic drugs, including clopidogrel, are approved by the Food and Drug Administration (FDA) [7]. To gain approval, a generic drug manufacturer must demonstrate that their product is bioequivalent to the reference listed drug (in this case, Plavix) [7]. This means the generic version delivers the same amount of active ingredient into the bloodstream in the same amount of time [7].
Sources:
[1] https://www.drugpatentwatch.com/blog/clopidogrel-bisulfate-market-and-patent-landscape
[2] https://www.drugpatentwatch.com/blog/antiplatelet-drug-market-overview
[3] https://www.drugpatentwatch.com/blog/plavix-patent-expiration-and-generic-competition
[4] https://www.drugpatentwatch.com/drugs/clopidogrel-bisulfate
[5] https://www.drugpatentwatch.com/blog/dual-antiplatelet-therapy-market-trends
[6] https://www.drugpatentwatch.com/blog/understanding-drug-exclusivity-and-patent-cliffs
[7] https://www.drugpatentwatch.com/blog/navigating-the-drug-approval-process-for-generics